Skip to content

The AMD Experts

teamphoto

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to create AMD Centers of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Article: September 2, 2020 | Insight Ophthalmic News

AdaptDx Pro Headset Set for Australian Debut

MacuLogix is launching its AdaptDx Pro device, which will be distributed in Australia by Optos pending Therapeutic Goods Administration approval.

Article: August 15, 2020 | Review of Optometric Business

Updates Come in Threes

Paul M. Karpecki, OD, dives into replacing or upgrading tests patients and staff dislike to ones that benefit everyone.

Article: August 12, 2020 | Review of Optometric Business

AMD: An Evolving Area of Revenue Growth in Optometric Practice

Craig Bowen, OD, (owner of Tualatin Eye Associates) discusses how change is often necessary in order to grow one's practice.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.